ghk-cu receptor downregulation desensitization tolerance The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline Blockade of glucagon receptor induces
Description
The comparison illustrates the difference between extensive clinical validation and promising but unvalidated preclinical data

Comparison: GHK-Cu vs

BPC-157 handles soft tissue repair and gut protection

2.5 mg per injection 25 units Frequency Daily (5 on / 2 off) Weekly Total ~12.5 mg Cycle Length 4 6 weeks ~12.5 mg/wk 5 mg per injection 15 units Frequency Daily (5 on / 2 off) Weekly Total ~25 mg Cycle Length 6 8 weeks ~25 mg/wk 5 10 mg per injection 15 30 units Frequency Daily (5 on / 2 off) Weekly Total 25 50 mg Cycle Length 6 8 weeks 25 50 mg/wk Weekly Schedule All protocols follow a 5-on / 2-off injection pattern
